Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use

NCT02158117 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Norwegian University of Science and Technology

Collaborators